Abstract
Cardiac fibrosis occurs in response to numerous factors including ischemia, myocardial scarring after infarction, pressure overload of the heart, and a complex interplay of multiple hormonal systems. Transforming growth factor-beta (TGF-β) is a locally generated cytokine that participates in healing processes and tissue fibrosis following cardiac injury. TGF-β1 induces the proliferation of cardiac fibroblasts and their phenotypic transformation to myofibroblasts, and the deposition of extracellular matrix (ECM). This review examines current knowledge on TGF-β signal transduction pathways and the effects of TGF-β inhibition on the development of cardiac fibrosis. Improved understanding of the actions and signaling of this cytokine system may lead to the development of new therapeutic strategies that combat the development of myocardial fibrosis in the pathogenesis of heart failure.
Keywords: Transforming growth factor-beta, inhibition, cardiac fibrosis
Current Enzyme Inhibition
Title: The Role of Transforming Growth Factor-β in Cardiac Fibrosis
Volume: 6 Issue: 2
Author(s): Leigh J. Ellmers
Affiliation:
Keywords: Transforming growth factor-beta, inhibition, cardiac fibrosis
Abstract: Cardiac fibrosis occurs in response to numerous factors including ischemia, myocardial scarring after infarction, pressure overload of the heart, and a complex interplay of multiple hormonal systems. Transforming growth factor-beta (TGF-β) is a locally generated cytokine that participates in healing processes and tissue fibrosis following cardiac injury. TGF-β1 induces the proliferation of cardiac fibroblasts and their phenotypic transformation to myofibroblasts, and the deposition of extracellular matrix (ECM). This review examines current knowledge on TGF-β signal transduction pathways and the effects of TGF-β inhibition on the development of cardiac fibrosis. Improved understanding of the actions and signaling of this cytokine system may lead to the development of new therapeutic strategies that combat the development of myocardial fibrosis in the pathogenesis of heart failure.
Export Options
About this article
Cite this article as:
J. Ellmers Leigh, The Role of Transforming Growth Factor-β in Cardiac Fibrosis, Current Enzyme Inhibition 2010; 6 (2) . https://dx.doi.org/10.2174/157340810791233024
DOI https://dx.doi.org/10.2174/157340810791233024 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design microRNA Decay: Refining microRNA Regulatory Activity
MicroRNA Thalidomide: An Overview of its Pharmacological Mechanisms of Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Congestive Heart Failure: Pharmacological Agents and the Potential of BType Natriuretic Peptide
Current Medicinal Chemistry Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Demystifying the ACE Polymorphism: From Genetics to Biology
Current Pharmaceutical Design Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction
CNS & Neurological Disorders - Drug Targets Involvement of the Mitochondrial Benzodiazepine Receptor in Traumatic Brain Injury: Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Global Safety of Coxibs and NSAIDs
Current Topics in Medicinal Chemistry The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes
Current Vascular Pharmacology Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets The Evolving Roles of Nuclear Cardiology
Current Cardiology Reviews Patent Selections:
Recent Patents on Regenerative Medicine Neuro-Psychological Pattern in Patients Suffering from Primitive Dilated Cardiomyopathy with Impairment in Executive Function
Current Neurovascular Research The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease
Current Medicinal Chemistry The Heat Stress Response and Diabetes: More Room for Mitochondrial Implication
Current Pharmaceutical Design Open Questions about Pulmonary Hypertension and Exercise Training: A Critical Review
Current Respiratory Medicine Reviews Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy